FRAMINGHAM, Mass., June 03, 2025 - Definitive Healthcare Corp. (Nasdaq: DH) has announced the approval of an inducement award for its newly appointed Chief Commercial Officer, Tina Hannagan. The award, granted by the Human Capital Management and Compensation Committee of the company's Board of Directors, consists of 830,565 time-based restricted stock units (RSUs), effective June 1, 2025. The award was individually negotiated and aligns with Nasdaq Listing Rule 5635(c)(4), serving as an inducement material to Ms. Hannagan's employment commencement. Under the terms of Definitive Healthcare's 2023 Inducement Plan, 25% of the RSUs are set to vest on June 1, 2026, with the remaining RSUs vesting in quarterly installments of 6.25% over the following three years, contingent upon Ms. Hannagan's continued employment with the company.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.